Compare HUDI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUDI | PMN |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Pharmaceuticals and Biotechnology |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 23.5M |
| IPO Year | 2021 | N/A |
| Metric | HUDI | PMN |
|---|---|---|
| Price | $1.26 | $8.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $72.67 |
| AVG Volume (30 Days) | 22.8K | ★ 22.8K |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $66,566,370.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.06 | $6.27 |
| 52 Week High | $5.46 | $39.75 |
| Indicator | HUDI | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 64.96 |
| Support Level | $1.10 | $6.62 |
| Resistance Level | $1.30 | $8.73 |
| Average True Range (ATR) | 0.06 | 0.56 |
| MACD | 0.01 | -0.31 |
| Stochastic Oscillator | 66.67 | 63.19 |
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.